Literature DB >> 27762119

Life-Threatening Thrombo-embolic Events in a Case of Dengue Hemorrhagic Fever.

Arun Agarwal1, Samiksha Sharma2, Mala Airun3.   

Abstract

In Dengue Hemorrhagic Fever (DHF), hemorrhagic manifestations are common but thrombotic events are uncommonly reported, despite the wide range of increased procoagulant activity during Dengue Fever illness. We report a case of a 55-year-old man of Asian Indian ethnicity who developed large vein thrombotic event -Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in the acute phase of DHF. His condition was further complicated by associated thrombocytopenia. The etiological connections between dengue viral infection with thrombocytopenia, DVT/PE and abnormal thrombophilia profile as well as the treatment dilemmas posed in treating a patient of DF with hemorrhagic manifestations and associated DVT/PE, and the role of eltrombopag are discussed. © Journal of the Association of Physicians of India 2011.

Entities:  

Mesh:

Year:  2016        PMID: 27762119

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  4 in total

1.  Dengue fever as a rare cause of pulmonary embolism.

Authors:  Francesco Poletto; Lorenzo Cerruti; Luca Spiezia
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

2.  Major acute cardiovascular events after dengue infection-A population-based observational study.

Authors:  Kai-Che Wei; Cheng-Len Sy; Wen-Hwa Wang; Chia-Ling Wu; Shang-Hung Chang; Yu-Tung Huang
Journal:  PLoS Negl Trop Dis       Date:  2022-02-07

3.  Dengue shock syndrome complicated with acute liver failure and kidney injury, infective endocarditis, and deep vein thrombosis: a case report.

Authors:  Keshinie Samarasekara; Janake Munasinghe
Journal:  J Med Case Rep       Date:  2018-10-30

4.  An unusual case of dengue shock syndrome complicated by ilio-femoral deep vein thrombosis; a case report.

Authors:  K M I U Ranasinghe; D Dissanayaka; K Thirumavalavan; M Seneviratne
Journal:  BMC Infect Dis       Date:  2020-05-12       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.